GN–G4 was highly expressed in 17 human malignancies, including adenoid cystic carcinoma (ACC), invasive breast cancer (BRCA), bile duct cell carcinoma (CHOL), and colonic adenocarcinoma (COAD) (Figure 1I). This evidence concerns the gene GNG4 and invasive breast carcinoma.